Electronic Health Record-Based Detection of Risk Factors for Clostridium difficile Infection Relapse

被引:43
|
作者
Hebert, Courtney [1 ]
Du, Hongyan [2 ]
Peterson, Lance R. [3 ]
Robicsek, Ari [4 ,5 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, Columbus, OH 43210 USA
[2] NorthShore Univ HealthSyst, Ctr Clin & Res Informat, Evanston, IL USA
[3] NorthShore Univ HealthSyst, Dept Pathol, Evanston, IL USA
[4] NorthShore Univ HealthSyst, Ctr Clin & Res Informat, Dept Hlth Informat Technol, Dept Med, Evanston, IL USA
[5] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源
关键词
PROTON-PUMP INHIBITORS; VANCOMYCIN; DIARRHEA; ASSOCIATION; RECURRENCE; THERAPY; STRAIN; DRUGS;
D O I
10.1086/669864
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. A major challenge in treating Clostridium difficile infection (CDI) is relapse. Many new therapies are being developed to help prevent this outcome. We sought to establish risk factors for relapse and determine whether fields available in an electronic health record (EHR) could be used to identify high-risk patients for targeted relapse prevention strategies. DESIGN. Retrospective cohort study. SETTING. Large clinical data warehouse at a 4-hospital healthcare organization. PARTICIPANTS. Data were gathered from January 2006 through October 2010. Subjects were all inpatient episodes of a positive C. difficile test where patients were available for 56 days of follow-up. METHODS. Relapse was defined as another positive test between 15 and 56 days after the initial test. Multivariable regression was performed to identify factors independently associated with CDI relapse. RESULTS. Eight hundred twenty-nine episodes met eligibility criteria, and 198 resulted in relapse (23.9%). In the final multivariable analysis, risk of relapse was associated with age (odds ratio [OR], 1.02 per year [95% confidence interval (CI), 1.01-1.03]), fluoroquinolone exposure in the 90 days before diagnosis (OR, 1.58 [95% CI, 1.11-2.26]), intensive care unit stay in the 30 days before diagnosis (OR, 0.47 [95% CI, 0.30-0.75]), cephalosporin (OR, 1.80 [95% CI, 1.19-2.71]), proton pump inhibitor (PPI; OR, 1.55 [95% CI, 1.05-2.29]), and metronidazole exposure after diagnosis (OR, 2.74 [95% CI, 1.64-4.60]). A prediction model tuned to ensure a 50% probability of relapse would flag 14.6% of CDI episodes. CONCLUSIONS. Data from a comprehensive EHR can be used to identify patients at high risk for CDI relapse. Major risk factors include antibiotic and PPI exposure. Infect Control Hosp Epidemiol 2013;34(4):407-414
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [11] Clostridium difficile infection in hospitals:: risk factors and responses
    Louie, TJ
    Meddings, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) : 45 - 46
  • [12] Risk factors for Clostridium difficile infection in a Hepatology ward
    Vanjak, Dominique
    Girault, Guillaume
    Branger, Catherine
    Rufat, Pierre
    Valla, Dominique-Charles
    Fantin, Bruno
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (02): : 202 - 204
  • [13] Clostridium difficile infection: epidemiology, risk factors and management
    Ashwin N. Ananthakrishnan
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 : 17 - 26
  • [14] Clostridium Difficile Infection: Risk Factors, Diagnosis and Management
    Christina M. Surawicz
    Current Treatment Options in Gastroenterology, 2015, 13 (1) : 121 - 129
  • [15] Risk Factors for Mortality in Patients With Clostridium difficile Infection
    Huttunen, Reetta
    Aittoniemi, Janne
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (08) : 1214 - 1214
  • [16] Epidemiology and Risk Factors for Clostridium difficile Infection in Children
    Sandora, Thomas J.
    Fung, Monica
    Flaherty, Kathleen
    Helsing, Laura
    Scanlon, Patricia
    Potter-Bynoe, Gail
    Gidengil, Courtney A.
    Lee, Grace M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (07) : 580 - 584
  • [17] Risk factors for Clostridium difficile infection in cirrhotic patients
    Dong Yan
    Yan-Di Huang
    Yun-Bo Chen
    Tao Lv
    Si-Lan Gu
    Yong-Tao Li
    Jian-Rong Huang
    Lan-Juan Li
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (03) : 237 - 241
  • [18] Electronic Health Record-Based Screening for Substance Abuse
    Alemi, Farrokh
    Avramovic, Sanja
    Schwartz, Mark D.
    BIG DATA, 2018, 6 (03) : 214 - 224
  • [19] Risk factors for mortality in patients with Clostridium difficile infection
    Perez-Cruz, Elizabeth
    Graciela Sandoval-Flores, Maria
    GACETA MEDICA DE MEXICO, 2019, 155 (04): : 343 - 349
  • [20] Clostridium difficile: A prospective study of infection risk factors
    Guevara, Rudolfo
    Silverman, Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S217 - S217